In contrast to the natively expressed SBDS that acts as an oncogenic protein, aberrant expression of SBDS in the nucleoplasm in response to ribosomal stress suppresses tumor cell growth in vitro and in vivo by inhibiting MDM2-mediated p53 degradation. The gene discussed is MDM2; the disease is neoplasm.